Author:
Kverno Karan,Ramos-Marcuse Fatima
Abstract
Recent widely publicized shortages in the U.S. supply of first-line medications for treatment of attention-deficit/hyperactivity disorder (ADHD) are thought to reflect increases in public awareness, help seeking, and treatment. ADHD is one of the most common neurodevelopmental disorders and is typically identified in childhood. In adulthood, ADHD symptoms are less likely to include hyperactivity, but inattention, impulsivity, and emotional dysregulation are common. Clinical evaluation of symptomatic adults who were not diagnosed as children requires corroboration of ADHD diagnostic symptoms in childhood and careful differentiation of ADHD from frequently co-occurring psychiatric and substance use disorders. Treatment of adult ADHD can result in improved functioning across multiple dimensions and comorbid disorders. Existing guidelines and consensus statements recommend an integrated approach to treating ADHD and all existing comorbid disorders, prioritizing the disorder that is creating the most difficulty for the individual. [
Journal of Psychosocial Nursing and Mental Health Services, 62
(1), 8–11.]
Reference33 articles.
1. The Effects of Nicotine and Tobacco Use on Brain Reward Function: Interaction With Nicotine Dependence Severity
2. American Professional Society of ADHD and Related Disorders. (2023, August). The first U.S. guidelines for adult ADHD to be released by the American Professional Society of ADHD and related disorders (APSARD.org). https://apsard.org/wp-content/uploads/2022/08/APSARD-Adult-ADHD-Guidelines-Press-Release.pdf
3. Diagnostic and Statistical Manual of Mental Disorders
4. Challenges of Treating ADHD with Comorbid Substance Use Disorder: Considerations for the Clinician
5. Barkley, R. A. (2011). Barkley Adult ADHD Rating Scale-IV (BAARS-IV)s. The Guilford Press.